{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:06:36Z","timestamp":1777572396076,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12955-019-1207-9","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T11:02:29Z","timestamp":1565262149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Health related quality of life among children with transfusion dependent \u03b2-thalassaemia major and haemoglobin E \u03b2-thalassaemia in Sri Lanka: a case control study"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0760-0418","authenticated-orcid":false,"given":"Sachith","family":"Mettananda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hashan","family":"Pathiraja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindu","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dayananda","family":"Bandara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udaya","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chamila","family":"Mettananda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuja","family":"Premawardhena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,8]]},"reference":[{"issue":"9813","key":"1207_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0140-6736(11)60283-3","volume":"379","author":"DR Higgs","year":"2012","unstructured":"Higgs DR, Engel JD, Stamatoyannopoulos G. Thalassaemia Lancet. 2012;379(9813):373\u201383.","journal-title":"Thalassaemia Lancet"},{"issue":"2","key":"1207_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.hoc.2017.11.003","volume":"32","author":"S Mettananda","year":"2018","unstructured":"Mettananda S, Higgs DR. Molecular basis and genetic modifiers of thalassemia. Hematol Oncol Clin North Am. 2018;32(2):177\u201391.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"10116","key":"1207_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0140-6736(17)31822-6","volume":"391","author":"AT Taher","year":"2018","unstructured":"Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet. 2018;391(10116):155\u201367.","journal-title":"Thalassaemia. Lancet."},{"key":"1207_CR4","doi-asserted-by":"crossref","unstructured":"Mettananda S, Gibbons RJ, Higgs DR. alpha-globin as a molecular target in treatment of beta-thalassemia. Blood. 2015.","DOI":"10.1182\/blood-2015-03-633594"},{"issue":"1","key":"1207_CR5","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41467-017-00479-7","volume":"8","author":"S Mettananda","year":"2017","unstructured":"Mettananda S, Fisher CA, Hay D, Badat M, Quek L, Clark K, et al. Editing an \u03b1-globin enhancer in primary human hematopoietic stem cells as a treatment for \u03b2-thalassemia. Nat Commun. 2017;8(1):424.","journal-title":"Nat Commun"},{"issue":"3","key":"1207_CR6","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.3324\/haematol.2016.155655","volume":"102","author":"S Mettananda","year":"2017","unstructured":"Mettananda S, Fisher CA, Sloane-Stanley JA, Taylor S, Oppermann U, Gibbons RJ, et al. Selective silencing of alpha-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of beta-thalassemia. Haematologica. 2017;102(3):e80\u2013e4.","journal-title":"Haematologica."},{"issue":"7577","key":"1207_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nature15521","volume":"527","author":"MC Canver","year":"2015","unstructured":"Canver MC, Smith EC, Sher F, Pinello L, Sanjana NE, Shalem O, et al. BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis. Nature. 2015;527(7577):192\u20137.","journal-title":"Nature."},{"issue":"16","key":"1207_CR8","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","volume":"378","author":"AA Thompson","year":"2018","unstructured":"Thompson AA, Walters MC, Kwiatkowski J, Rasko JEJ, Ribeil JA, Hongeng S, et al. Gene therapy in patients with transfusion-dependent beta-thalassemia. N Engl J Med. 2018;378(16):1479\u201393.","journal-title":"N Engl J Med"},{"issue":"2","key":"1207_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.hoc.2017.11.005","volume":"32","author":"A Marcon","year":"2018","unstructured":"Marcon A, Motta I, Taher AT, Cappellini MD. Clinical complications and their management. Hematol Oncol Clin North Am. 2018;32(2):223\u201336.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"1207_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4038\/sljch.v47i2.8484","volume":"47","author":"S Mettananda","year":"2018","unstructured":"Mettananda S. Management of Thalassaemia. Sri Lanka Journal of Child Health. 2018;47(2):159\u201365.","journal-title":"Sri Lanka Journal of Child Health"},{"key":"1207_CR11","volume-title":"Guidelines for the management of transfusion dependent thalassaemia (TDT) 3rd edition ed.","author":"MD Cappellini","year":"2014","unstructured":"Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V. In: Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V, editors. Guidelines for the management of transfusion dependent thalassaemia (TDT) 3rd edition ed. Cyprus: Thalassaemia International Federation; 2014."},{"issue":"4","key":"1207_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.blre.2018.02.001","volume":"32","author":"MD Cappellini","year":"2018","unstructured":"Cappellini MD, Porter JB, Viprakasit V, Taher AT. A paradigm shift on beta-thalassaemia treatment: how will we manage this old disease with new therapies? Blood Rev. 2018;32(4):300\u201311.","journal-title":"Blood Rev"},{"issue":"6","key":"1207_CR13","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1365-2141.2011.08742.x","volume":"154","author":"DJ Weatherall","year":"2011","unstructured":"Weatherall DJ. The challenge of haemoglobinopathies in resource-poor countries. Br J Haematol. 2011;154(6):736\u201344.","journal-title":"Br J Haematol"},{"key":"1207_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/9780470696705","volume-title":"The thalassaemia syndromes","author":"DJ Weatherall","year":"2001","unstructured":"Weatherall DJ, Clegg JB. The thalassaemia syndromes. 4th ed. Oxford: Blackwell Science; 2001.","edition":"4"},{"issue":"11","key":"1207_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206928","volume":"13","author":"S Mettananda","year":"2018","unstructured":"Mettananda S, Suranjan M, Fernando R, Dias T, Mettananda C, Rodrigo R, et al. Anaemia among females in child-bearing age: relative contributions, effects and interactions of alpha- and beta-thalassaemia. PLoS One. 2018;13(11):e0206928.","journal-title":"PLoS One"},{"issue":"3","key":"1207_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/bjh.14437","volume":"176","author":"A Premawardhena","year":"2017","unstructured":"Premawardhena A, Allen A, Piel F, Fisher C, Perera L, Rodrigo R, et al. The evolutionary and clinical implications of the uneven distribution of the frequency of the inherited haemoglobin variants over short geographical distances. Br J Haematol. 2017;176(3):475\u201384.","journal-title":"Br J Haematol"},{"issue":"5","key":"1207_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27643","volume":"66","author":"S Mettananda","year":"2019","unstructured":"Mettananda S, Pathiraja H, Peiris R, Wickramarathne N, Bandara D, de Silva U, et al. Blood transfusion therapy for beta-thalassemia major and hemoglobin E beta-thalassemia: adequacy, trends, and determinants in Sri Lanka. Pediatr Blood Cancer. 2019;66(5):e27643.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"1207_CR18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1186\/s13104-018-3634-9","volume":"11","author":"T Suriapperuma","year":"2018","unstructured":"Suriapperuma T, Peiris R, Mettananda C, Premawardhena A, Mettananda S. Body iron status of children and adolescents with transfusion dependent beta-thalassaemia: trends of serum ferritin and associations of optimal body iron control. BMC Res Notes. 2018;11(1):547.","journal-title":"BMC Res Notes"},{"issue":"3","key":"1207_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4038\/sljch.v46i3.8318","volume":"46","author":"S Mettananda","year":"2017","unstructured":"Mettananda S. Thalassaemia: in a quest towards an ultimate cure. Sri Lanka Journal of Child Health. 2017;46(3):203\u201310.","journal-title":"Sri Lanka Journal of Child Health."},{"key":"1207_CR20","first-page":"1","volume":"10","author":"M Thavorncharoensap","year":"2010","unstructured":"Thavorncharoensap M, Torcharus K, Nuchprayoon I, Riewpaiboon A, Indaratna K, Ubol BO. Factors affecting health-related quality of life in Thai children with thalassemia. BMC Blood Disord. 2010;10:1.","journal-title":"BMC Blood Disord"},{"key":"1207_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1196\/annals.1345.059","volume":"1054","author":"Z Pakbaz","year":"2005","unstructured":"Pakbaz Z, Treadwell M, Yamashita R, Quirolo K, Foote D, Quill L, et al. Quality of life in patients with thalassemia intermedia compared to thalassemia major. Ann N Y Acad Sci. 2005;1054:457\u201361.","journal-title":"Ann N Y Acad Sci"},{"key":"1207_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1196\/annals.1345.035","volume":"1054","author":"P Telfer","year":"2005","unstructured":"Telfer P, Constantinidou G, Andreou P, Christou S, Modell B, Angastiniotis M. Quality of life in thalassemia. Ann N Y Acad Sci. 2005;1054:273\u201382.","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"1207_CR23","first-page":"1157","volume":"89","author":"A Cao","year":"2004","unstructured":"Cao A. Quality of life and survival of patients with beta-thalassemia major. Haematologica. 2004;89(10):1157\u20139.","journal-title":"Haematologica."},{"key":"1207_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1477-7525-10-105","volume":"10","author":"MN Danansuriya","year":"2012","unstructured":"Danansuriya MN, Rajapaksa LC. Psychometric properties of the Sinhala version of the PedsQL 4.0 generic Core scales in early adolescents in Sri Lanka. Health Qual Life Outcomes. 2012;10:105.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"1207_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/archdischild-2016-310694","volume":"102","author":"N Ranasinghe","year":"2017","unstructured":"Ranasinghe N, Devanarayana NM, Benninga MA, van Dijk M, Rajindrajith S. Psychological maladjustment and quality of life in adolescents with constipation. Arch Dis Child. 2017;102(3):268\u201373.","journal-title":"Arch Dis Child"},{"key":"1207_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-230X-14-150","volume":"14","author":"NM Devanarayana","year":"2014","unstructured":"Devanarayana NM, Rajindrajith S, Benninga MA. Quality of life and health care consultation in 13 to 18 year olds with abdominal pain predominant functional gastrointestinal diseases. BMC Gastroenterol. 2014;14:150.","journal-title":"BMC Gastroenterol"},{"issue":"17","key":"1207_CR27","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1182\/blood-2018-06-818187","volume":"132","author":"AT Taher","year":"2018","unstructured":"Taher AT, Cappellini MD. How I manage medical complications of beta-thalassemia in adults. Blood. 2018;132(17):1781\u201391.","journal-title":"Blood."},{"issue":"3","key":"1207_CR28","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/bjh.12631","volume":"164","author":"RJ Klaassen","year":"2014","unstructured":"Klaassen RJ, Barrowman N, Merelles-Pulcini M, Vichinsky EP, Sweeters N, Kirby-Allen M, et al. Validation and reliability of a disease-specific quality of life measure (the TranQol) in adults and children with thalassaemia major. Br J Haematol. 2014;164(3):431\u20137.","journal-title":"Br J Haematol"},{"issue":"1","key":"1207_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12955-018-0893-z","volume":"16","author":"GLA Hakeem","year":"2018","unstructured":"Hakeem GLA, Mousa SO, Moustafa AN, Mahgoob MH, Hassan EE. Health-related quality of life in pediatric and adolescent patients with transfusion-dependent ss-thalassemia in upper Egypt (single center study). Health Qual Life Outcomes. 2018;16(1):59.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"1207_CR30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2141.2008.07126.x","volume":"141","author":"NF Olivieri","year":"2008","unstructured":"Olivieri NF, Muraca GM, O'Donnell A, Premawardhena A, Fisher C, Weatherall DJ. Studies in haemoglobin E beta-thalassaemia. Br J Haematol. 2008;141(3):388\u201397.","journal-title":"Br J Haematol"},{"issue":"2","key":"1207_CR31","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11136-018-1986-1","volume":"28","author":"M Arian","year":"2019","unstructured":"Arian M, Mirmohammadkhani M, Ghorbani R, Soleimani M. Health-related quality of life (HRQoL) in beta-thalassemia major (beta-TM) patients assessed by 36-item short form health survey (SF-36): a meta-analysis. Qual Life Res. 2019;28(2):321\u201334.","journal-title":"Qual Life Res"},{"issue":"2","key":"1207_CR32","first-page":"57","volume":"4","author":"S Ansari","year":"2014","unstructured":"Ansari S, Baghersalimi A, Azarkeivan A, Nojomi M, Hassanzadeh RA. Quality of life in patients with thalassemia major. Iran J Ped Hematol Oncol. 2014;4(2):57\u201363.","journal-title":"Iran J Ped Hematol Oncol"},{"key":"1207_CR33","doi-asserted-by":"crossref","unstructured":"Sleiman J, Tarhini A, Bou-Fakhredin R, Saliba AN, Cappellini MD, Taher AT. Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management. Int J Mol Sci. 2018;19(1).","DOI":"10.3390\/ijms19010182"},{"key":"1207_CR34","volume-title":"Guidelines for the management of non transfusion dependent thalassaemia (NTDT) Cyprus: Thalassaemia international federation","author":"A Taher","year":"2013","unstructured":"Taher A, Vichinsky E, Musallam K, Cappellini MD, Viprakasit V. Guidelines for the management of non transfusion dependent thalassaemia (NTDT) Cyprus: Thalassaemia international federation; 2013."}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-019-1207-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12955-019-1207-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-019-1207-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T23:16:23Z","timestamp":1596755783000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-019-1207-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,8]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1207"],"URL":"https:\/\/doi.org\/10.1186\/s12955-019-1207-9","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,8]]},"assertion":[{"value":"1 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Parents of the participants were briefed about the study and informed written consent from guardians and assent from children over 12\u2009years were obtained before recruiting into the study. Ethical approval was obtained from the Ethics Review Committee of University of Kelaniya, Sri Lanka.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}